Prospera Financial Services Inc Syndax Pharmaceuticals Inc Transaction History

Prospera Financial Services Inc

  • $3.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$13.64 - $19.48 $51,572 - $73,653
-3,781 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$14.84 - $22.15 $56,110 - $83,749
3,781 New
3,781 $66,000
Q4 2020

Feb 12, 2021
SELL
$15.1 - $26.44 $30,683 - $53,726
-2,032 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$13.39 - $17.48 $27,208 - $35,519
2,032 New
2,032 $30,000

Others Institutions Holding SNDX

# of Institutions
229
Shares Held
88.4M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $934M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email